The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics
暂无分享,去创建一个
G Poste | G. Poste | I. Chopra | B. Metcalf | J. Hodgson | I Chopra | J Hodgson | B Metcalf | J. Hodgson
[1] I. Chopra,et al. An assay to detect inhibitors of bacterial iron transport. , 1994, Journal of antibiotics (Tokyo. 1968).
[2] Swartz Mn. Hospital-acquired infections: diseases with increasingly limited therapies. , 1994 .
[3] N. Georgopapadakou,et al. Strategies in β-lactam Design , 1992 .
[4] I. Chopra,et al. Bacterial resistance mechanisms as therapeutic targets. , 1994, The Journal of antimicrobial chemotherapy.
[5] J. Sutcliffe. Chapter 15. Novel Approaches Toward Discovery of Antibacterial Agents , 1988 .
[6] J. Shea,et al. Simultaneous identification of bacterial virulence genes by negative selection. , 1995, Science.
[7] J. Hearst,et al. Genes acrA and acrB encode a stress‐induced efflux system of Escherichia coli , 1995, Molecular microbiology.
[8] M. A. Wuonola,et al. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721 , 1987, Antimicrobial Agents and Chemotherapy.
[9] W V Shaw,et al. Bacterial resistance to chloramphenicol. , 1984, British medical bulletin.
[10] Y. Mechulam,et al. Aminoacyl-tRNA Synthetases: Occurrence, Structure, and Function , 1995 .
[11] G. Poste,et al. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. , 1996, JAMA.
[12] K. Bush,et al. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases. , 1995, The Journal of antimicrobial chemotherapy.
[13] J. Clark-Curtiss,et al. Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages , 1994, Infection and immunity.
[14] S. Levy,et al. Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.
[15] R. Jones,et al. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones , 1996, Antimicrobial agents and chemotherapy.
[16] J. Tobias,et al. Selection for bacterial genes that are specifically induced in host tissues: the hunt for virulence factors. , 1993, Infectious agents and disease.
[17] J M Hughes,et al. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. , 1996, Journal of the American Medical Association (JAMA).
[18] C Reading,et al. Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus , 1977, Antimicrobial Agents and Chemotherapy.
[19] O. Schneewind,et al. Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in Gram‐positive bacteria , 1994, Molecular microbiology.
[20] MJ Mahan,et al. Selection of bacterial virulence genes that are specifically induced in host tissues , 1993, Science.
[21] T. Nicas,et al. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria , 1995, Antimicrobial agents and chemotherapy.
[22] G. Dunny,et al. Genetics and Molecular Biology of Streptococci, Lactococci, and Enterococci , 1991 .
[23] W. Jacobs,et al. Molecular Genetic Strategies for Identifying Virulence Determinants of Mycobacterium tuberculosis , 1994 .
[24] Ernest Frederick Gale,et al. The Molecular basis of antibiotic action , 1972 .
[25] L. Piddock,et al. Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy? , 1996, The Journal of antimicrobial chemotherapy.
[26] C. Kunin,et al. Resistance to antimicrobial drugs--a worldwide calamity. , 1993, Annals of internal medicine.
[27] J. Tobias,et al. Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[28] K. Shannon. Understanding Antibacterial Action and Resistance , 1996 .
[29] A. Osbourn,et al. Identification of plant‐induced genes of the bacterial pathogen Xanthomonas campestris pathovar campestris using a promoter‐probe plasmid , 1987, The EMBO journal.
[30] J. Briat. Iron assimilation and storage in prokaryotes. , 1992, Journal of general microbiology.
[31] C. Kunin,et al. Resistance to Antimicrobial DrugsA Worldwide Calamity , 1993, Annals of Internal Medicine.
[32] R. Fleischmann,et al. The Minimal Gene Complement of Mycoplasma genitalium , 1995, Science.
[33] K. Wong,et al. Stress-inducible gene of Salmonella typhimurium identified by arbitrarily primed PCR of RNA. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[34] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[35] A. Tomasz,et al. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. , 1994, The New England journal of medicine.
[36] Y. Gluzman,et al. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines , 1994, Antimicrobial Agents and Chemotherapy.
[37] I. Chopra. Efflux-based antibiotic resistance mechanisms: the evidence for increasing prevalence. , 1992, The Journal of antimicrobial chemotherapy.
[38] G. Eliopoulos,et al. The carbapenems: new broad spectrum β-lactam antibiotics , 1989 .
[39] G. Ellestad,et al. Glycylcyclines: a new generation of tetracyclines. , 1995, The Journal of antimicrobial chemotherapy.
[40] R. Gustafson,et al. Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? , 1996 .
[41] V. Fischetti,et al. Common characteristics of the surface proteins from gram positive cocci , 1991 .
[42] T. Atkinson,et al. Molecular evolution of bacterial cell-surface proteins. , 1993, Trends in biochemical sciences.
[43] H. Labischinski,et al. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? , 1996, Microbial drug resistance.
[44] Michael McClelland,et al. Arbitrarily primed PCR fingerprinting of RNA. , 1992, Nucleic acids research.
[45] N. Bennett,et al. The use of antibiotics: A comprehensive review with clinical emphasis, , 1972 .
[46] R. Fleischmann,et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. , 1995, Science.
[47] M. Jacobs,et al. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci , 1996, Antimicrobial agents and chemotherapy.
[48] F. Quinn,et al. Methods for the Identification of Virulence Genes Expressed in Mycobacterium tuberculosis Strain H37Rc , 1994 .
[49] K. Cartwright. Fifty years of antimicrobials: Past perspectives and future trends. , 1996, Epidemiology and Infection.
[50] E. Culotta. Funding crunch hobbles antibiotic resistance research. , 1994, Science.
[51] R. Sykes,et al. Counteracting antibiotic resistance: new drugs. , 1984, British medical bulletin.
[52] J. Soothill. Treatment of experimental infections of mice with bacteriophages. , 1992, Journal of medical microbiology.
[53] I. Chopra,et al. SB 205952, a novel semisynthetic monic acid analog with at least two modes of action , 1995, Antimicrobial agents and chemotherapy.
[54] J. Mekalanos,et al. Use of genetic recombination as a reporter of gene expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[55] G. Kaatz,et al. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis , 1996, Antimicrobial agents and chemotherapy.
[56] Y. Sumita,et al. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus , 1995, Antimicrobial agents and chemotherapy.
[57] M. Finland,et al. Effect of Inoculum and of Beta-Lactamase on the Anti-Staphylococcal Activity of Thirteen Penicillins and Cephalosporins , 1975, Antimicrobial Agents and Chemotherapy.
[58] F. Quinn,et al. The identification of bacterial gene expression differences using mRNA-based isothermal subtractive hybridization. , 1995, Canadian journal of microbiology.
[59] A. Yamaguchi,et al. A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter , 1995, Antimicrobial agents and chemotherapy.
[60] G. Eliopoulos,et al. Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria , 1995, Antimicrobial agents and chemotherapy.
[61] M. Swartz,et al. Hospital-acquired infections: diseases with increasingly limited therapies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[62] M. Arthur,et al. Genetics and mechanisms of glycopeptide resistance in enterococci , 1993, Antimicrobial Agents and Chemotherapy.
[63] H. Neu,et al. The Crisis in Antibiotic Resistance , 1992, Science.
[64] J. Hughes,et al. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. , 1978, The Biochemical journal.
[65] J. Hughes,et al. On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. , 1978, The Journal of antibiotics.
[66] Mitchell L. Cohen. Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era , 1992, Science.
[67] F. Blattner,et al. Global regulation of gene expression in Escherichia coli , 1993, Journal of bacteriology.
[68] L. Larsson,et al. A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis , 1987, Nature.